Scotiabank Has Lowered Expectations for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price
Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) had its price target decreased by Scotiabank from $52.00 to $51.00 in a research report released on Monday,Benzinga reports. Scotiabank currently has a sector outperform rating on the biotechnology company’s stock. Other equities analysts have also issued reports about the stock. The Goldman Sachs Group lowered their target price […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) had its price target decreased by Scotiabank from $52.00 to $51.00 in a research report released on Monday,Benzinga reports. Scotiabank currently has a sector outperform rating on the biotechnology company’s stock. Other equities analysts have also issued reports about the stock. The Goldman Sachs Group lowered their target price […]
